Breaking NEWS to Breaking wallets. hmmm! Now this is getting interesting.
has been designated as an Orphan Drug by the European Medicines Agency for gastric cancer . The drug has previously received Orphan Drug designation by the U.S. Food and Drug Administration for both gastric cancer and melanoma, as well as Fast Track designation by FDA for gastric cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.